banner 2022-08-26
  • Precision diagnostics within touch

    Precision diagnostics within touch

    Core-lab precision
    hs-cTnI ≤0.006ng/ml
    Results in 15 minutes
  • Hardcore Innovation

    Hardcore Innovation

    Versatile bead separation
    Intelligent single photon counting module
    Remote maintenance and upgrade
    Software define immunoassay
    Automatic optical inspection
  • Whole chain controllable

    Whole chain controllable

    One-stop service including upstream manufactured parts,
    instrument customization,
    reagent development,
    OEM and CDMO etc.
  • 5A products

    5A products



  • Illumaxbio is constantly striving to be a global point-of-care innovator.
Read More
  • default

About Company

Illumaxbio founded on August 30, 2018, is a national high-tech enterprise. The company specializes in the research and manufacturing of single-test chemiluminescence system, single-test multiplex immunoassay system, and laboratory automation products, and provides an open ecological platform and comprehensive solutions for chemiluminescence and multiplex immunoassay in the industry.

The company has accumulated long-term technical expertise in the fields of chemiluminescence, multiplex immunoassay, encoded microspheres, diagnostic reagents, core components, and single-test reagent production equipment. It has also developed multiplex proprietary technologies. The company has built a “5A-level” diagnostic system that has reached new heights in the industry. Its products have covered Europe, the Middle East, South Asia, South America, Africa, and major provinces, cities, and autonomous regions in China, earning unanimous praise from domestic and international customers. Illumaxbio will continue to focus on clinical value and clinical demands, providing accessible and precise diagnostic solutions for global partners, and striving to become a value innovator in the global IVD industry!

Read More



Xingpeng Zhang,the founder and CEO of illumaxbio, received BMEE from Xi’an Jiao Tong University, and MBA from University of Electronic Science and Technology of China. He has been engaged in the IVD R & D and manufacturing for 20 years. The core team start their in-vitro diagnostic R&D career from 2006, they have comprehensive experience in CLIA system, flow cytometry, lab automation, clinical chemistry analyzer etc. They are committed to developing innovative IVD products for the global market.